LPA - ACQUISITION OF INSULIN GLARGINE
About This Opportunity
TranslatedThis tender, identified as LPA - ACQUISITION OF INSULIN GLARGINE, concerns the procurement of insulin glargine. While the description is brief, it indicates a requirement for this specific pharmaceutical product. Insulin glargine is a long-acting basal insulin used in the management of diabetes mellitus, particularly type 1 and type 2 diabetes, to help control blood glucose levels. The tender likely seeks to secure a supply of this essential medication, potentially for a public health program, hospital, or other healthcare facility. Key aspects of the tender would typically include specifications for the insulin glargine (e.g., concentration, packaging, expiry dates), quantities required, delivery timelines, and eligibility criteria for bidders. Interested parties, likely pharmaceutical manufacturers or authorized distributors, should review the full tender documentation for detailed requirements regarding product quality, regulatory compliance, and submission procedures. The specific location and duration of the supply contract are expected to be detailed in the complete tender package. This acquisition is crucial for ensuring continued access to vital diabetes treatment for patients.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishThis tender, originating from Chile and published on the chile_mercadopublico platform, seeks the procurement of Insulin Glargine. The contracting authority is seeking to establish a supply contract for this essential pharmaceutical product. Insulin Glargine is a long-acting basal insulin analogue used in the management of diabetes mellitus, primarily to control blood glucose levels over an extended period.
Prospective bidders are invited to submit proposals for the supply of Insulin Glargine, likely in various presentations and dosages as specified in the detailed tender documents. Typical requirements for such pharmaceutical tenders often include adherence to stringent quality standards, relevant Good Manufacturing Practices (GMP), and compliance with national regulatory authority approvals in Chile. Bidders will be expected to demonstrate their capacity to reliably supply the required quantities, maintain product integrity during transit and storage, and provide comprehensive product information, including pharmacovigilance data. The tender process will likely involve evaluation based on technical specifications, quality assurance, pricing, and delivery capabilities. Further details regarding specific technical requirements, delivery schedules, contractual terms, and submission procedures are available within the full tender documentation accessible via the provided source.
This procurement is critical for ensuring the availability of vital medication for patients in Chile.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 24 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to INSTITUTO SANITAS S A. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
INSTITUTO SANITAS S A was awarded the contract for CLP 108,660,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.